Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

  • your selections
Clear Search

Filter Results

date

Topics

Tags

Content Type

  • results
  • state & global data
  • slides
The Policy Implications of Medicare’s New Measure of Financial Health

This report examines a new measure of Medicare’s financial health established by the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA). The report, authored by Marilyn Moon, takes an in-depth look at the program’s new solvency test, which measures general revenues as a share of total Medicare spending and can trigger a “funding warning” that compels the President to propose and the Congress to consider a funding warning.

2012 Survey of Americans on the U.S. Role in Global Health

The 2012 Survey of Americans on the U.S. Role in Global Health is the fourth in a series that aims to examine the American public’s views, knowledge and opinions of U.S. efforts to improve health for people in developing countries.

Medicaid Spending Growth in the Great Recession and Its Aftermath, FY 2007-2012

This report presents data on changes in Medicaid’s enrollment and spending between federal fiscal year 2007 and federal fiscal year 2012, a period which includes the worst economic downturn in the United States since the Great Depression. The paper also examines what factors drove Medicaid spending over the period, and concludes that overall spending growth from 2007 to 2012 was driven largely by the enrollment growth that resulted from many people losing jobs and income during the recession. However, on a per enrollee basis, Medicaid spending has grown more slowly than other sectors of the health system.

The Facts on Medicare Spending and Financing

This fact sheet provides an overview of spending on the Medicare program and how the program is financed. It examines historical, recent, and future trends in Medicare spending, including the recent slowdown partially attributable to provisions in the Affordable Care Act of 2010, and includes the latest available data on Medicare financing.

3 Takeaways From the Medicare Trustees Report

In his latest column for The Wall Street Journal’s Think Tank, Drew Altman dives into this week’s release of the Social Security and Medicare Trustees Report to discuss the good news that may have been missed.

Drew Altman: 3 Takeaways From the Medicare Trustees Report

In his latest column for The Wall Street Journal’s Think Tank, Drew Altman dives into this week’s release of the Social Security and Medicare Trustees Report to discuss the good news that may have been missed. All previous columns by Drew Altman are available online.

Medicare Part D Spending Trends: Understanding Key Drivers and the Role of Competition

This brief commissioned by the Foundation examines factors that contributed to Medicare’s lower-than-expected spending on prescription drugs under the Medicare Part D drug benefit that started in 2006. Since its launch, Medicare has spent about 30 percent less on Part D benefits than the Congressional Budget Office originally projected. Some…

Prescription Drug Procurement and the Federal Budget

This brief commissioned by the Foundation considers areas where Medicare faces limited opportunity for market-based competition and price negotiation to drive down drug spending. These areas include drug purchasing for low-income people enrolled in Part D plans who face minimal cost-sharing requirements, and purchasing certain unique drugs, such as biologicals,…